Phenotype
|
Fish
|
Conditions
|
Figures
|
cranium motor neuron isl2a expression spatial pattern, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: procainamide
|
Fig. 4
from Asad et al., 2019
|
cranium sensory neuron isl2a expression spatial pattern, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: CHIC-35
|
Fig. 4
from Asad et al., 2019
|
pharyngeal arch cartilage sox9a expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: CHIC-35
|
Fig. 3
from Asad et al., 2019
|
lateral line glial cell mbpa expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: procainamide
|
Fig. 5
from Asad et al., 2019
|
cranium sensory neuron isl2a expression spatial pattern, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 1
from Asad et al., 2019
|
lateral line glial cell mbpa expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: CHIC-35
|
Fig. 5
from Asad et al., 2019
|
pharyngeal arch cartilage sox9a expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: procainamide
|
Fig. 3
from Asad et al., 2019
|
cranium sensory neuron isl2a expression spatial pattern, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: procainamide
|
Fig. 4
from Asad et al., 2019
|
eye decreased size, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 1
from Asad et al., 2019
|
pericardium edematous, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 1
from Asad et al., 2019
|
lateral line glial cell mbpa expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
|
Fig. 5
from Asad et al., 2019
|
mandibular arch skeleton decreased size, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 1
from Asad et al., 2019
|
perichondrium sox9b expression decreased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: CHIC-35
|
Fig. 3
from Asad et al., 2019
|
trunk foxd3 expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: DAPT
|
Fig. 5
from Asad et al., 2019
|
glial cell mbpa expression decreased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 1
from Asad et al., 2019
|
trunk foxd3 expression increased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: procainamide
|
Fig. 5
from Asad et al., 2019
|
pharyngeal arch cartilage sox9a expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
|
Fig. 3
from Asad et al., 2019
|
trunk foxd3 expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: CHIC-35
|
Fig. 5
from Asad et al., 2019
|
perichondrium sox9b expression decreased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: DAPT
|
Fig. 3
from Asad et al., 2019
|
perichondrium sox9b expression decreased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 1
from Asad et al., 2019
|
pharyngeal arch cartilage sox9a expression decreased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 1
from Asad et al., 2019
|
trunk foxd3 expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
|
Fig. 5
from Asad et al., 2019
|
trunk foxd3 expression increased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2019
|
cranium motor neuron isl2a expression spatial pattern, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 1
from Asad et al., 2019
|
perichondrium sox9b expression decreased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
|
Fig. 3
from Asad et al., 2019
|
pharyngeal arch cartilage sox9a expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: DAPT
|
Fig. 3
from Asad et al., 2019
|
lateral line glial cell mbpa expression decreased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2019
|
cranium motor neuron isl2a expression spatial pattern, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: CHIC-35
|
Fig. 4
from Asad et al., 2019
|
lateral line glial cell mbpa expression amount, ameliorated
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: DAPT
|
Fig. 5
from Asad et al., 2019
|
perichondrium sox9b expression decreased amount, abnormal
|
TU + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: procainamide
|
Fig. 3
from Asad et al., 2019
|
neural keel sox2 expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 2
from Asad et al., 2016
|
vagal neural crest crestin expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|
eye iridophore absent, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
whole organism decreased pigmentation, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
whole organism sox10 expression increased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 3
from Asad et al., 2016
|
neural crest sox10 expression spatial pattern, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 3
from Asad et al., 2016
|
pericardium edematous, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
whole organism foxd3 expression increased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 2
from Asad et al., 2016
|
neuromast absent, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2016
|
neural crest cell snai2 expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 2
from Asad et al., 2016
|
cranial motor neuron isl2a expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|
myelinating Schwann cell mbpa expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
epibranchial cartilage neuroblast neurod1 expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2016
|
neural plate border sox10 expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 3
from Asad et al., 2016
|
melanocyte tyr expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
neural crest foxd3 expression increased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 2
from Asad et al., 2016
|
neural crest cell sox10 expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 3
from Asad et al., 2016
|
pharyngeal arch chondrocyte sox9a expression absent, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
lateral line glial cell (sensu Vertebrata) foxd3 expression increased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
myelinating Schwann cell foxd3 expression increased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
melanocyte dct expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
head decreased size, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
whole organism Melanin decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
somite foxd3 expression increased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 2
from Asad et al., 2016
|
trunk iridophore absent, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
whole organism melanocyte shape, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
neural crest cell migration delayed, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 3
from Asad et al., 2016
|
cranium glial cell (sensu Vertebrata) absent, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
myelinating Schwann cell myelination disrupted, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
pharyngeal arch neural crest cell dlx2a expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
myelinating Schwann cell mbpa expression decreased distribution, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
perichondrium disorganized, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
perichondrium sox9b expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
neural crest cell migration disrupted, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 2,
Fig. 3
from Asad et al., 2016
|
brain glial cell (sensu Vertebrata) egr2b expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. S6
from Asad et al., 2016
|
neural crest melanoblast mitfa expression increased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
motor neuron isl2a expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2016
|
neural crest cell sox9a expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 2
from Asad et al., 2016
|
cranium glial cell foxd3 expression absent, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
sensory neuron isl2a expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2016
|
head neuroblast neurod1 expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|
neuromast decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2016
|
migratory neural crest mislocalised, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 3
from Asad et al., 2016
|
lateral line glial cell egr2b expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. S6
from Asad et al., 2016
|
enteric neuron crestin expression decreased amount, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2016
|
ventral mandibular arch absent, abnormal
|
TU + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
ceratobranchial cartilage absent, abnormal
|
ba2Tg + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
Meckel's cartilage absent, abnormal
|
ba2Tg + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
olfactory receptor cell decreased amount, abnormal
|
ba2Tg + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|
trunk sox10 expression spatial pattern, abnormal
|
ba2Tg + MO8-chd7
|
standard conditions
|
Fig. 3
from Asad et al., 2016
|
ceratohyal cartilage absent, abnormal
|
ba2Tg + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
neural crest cell migration disrupted, abnormal
|
ba2Tg + MO8-chd7
|
standard conditions
|
Fig. 3
from Asad et al., 2016
|
neural crest melanoblast GFP expression increased amount, abnormal
|
w47Tg + MO8-chd7
|
control
|
Fig. 4
from Asad et al., 2016
|
whole organism decreased pigmentation, abnormal
|
w47Tg + MO8-chd7
|
standard conditions
|
Fig. S4
from Asad et al., 2016
|
head melanoblast GFP expression increased amount, abnormal
|
w47Tg + MO8-chd7
|
control
|
Fig. 4
from Asad et al., 2016
|
lateral line glial cell (sensu Vertebrata) GFP expression increased amount, abnormal
|
zf15Tg + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
lateral line glial cell (sensu Vertebrata) morphology, abnormal
|
zf15Tg + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
enteric neuron decreased amount, abnormal
|
zf148Tg + MO3-chd7 + MO8-chd7
|
standard conditions
|
Fig. 1
from Asad et al., 2019
|
pharyngeal arch cartilage morphology, ameliorated
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
|
Fig. 3
from Asad et al., 2019
|
enteric neuron decreased amount, abnormal
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: CHIC-35
|
Fig. 4
from Asad et al., 2019
|
pharyngeal arch cartilage morphology, ameliorated
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: procainamide
|
Fig. 3
from Asad et al., 2019
|
mandibular arch skeleton decreased size, abnormal
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
|
Fig. 3
from Asad et al., 2019
|
mandibular arch skeleton decreased size, abnormal
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: procainamide
|
Fig. 3
from Asad et al., 2019
|
mandibular arch skeleton decreased size, abnormal
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: DAPT
|
Fig. 3
from Asad et al., 2019
|
pharyngeal arch cartilage morphology, ameliorated
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: CHIC-35
|
Fig. 3
from Asad et al., 2019
|
enteric neuron decreased amount, abnormal
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: procainamide
|
Fig. 4
from Asad et al., 2019
|
mandibular arch skeleton decreased size, abnormal
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: CHIC-35
|
Fig. 3
from Asad et al., 2019
|
pharyngeal arch cartilage morphology, ameliorated
|
zf148Tg + MO3-chd7 + MO8-chd7
|
chemical treatment by environment: DAPT
|
Fig. 3
from Asad et al., 2019
|
enteric neuron decreased amount, abnormal
|
zf148Tg + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|
microvillous olfactory receptor neuron decreased amount, abnormal
|
zf148Tg + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2016
|
microvillous olfactory receptor neuron disorganized, abnormal
|
zf148Tg + MO8-chd7
|
standard conditions
|
Fig. 5
from Asad et al., 2016
|
head neuroblast neurod1 expression decreased amount, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|
pharyngeal arch chondrocyte sox9a expression absent, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
perichondrium sox9b expression decreased amount, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
melanocyte tyr expression decreased amount, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
pharyngeal arch neural crest cell dlx2a expression decreased amount, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
neural crest melanoblast mitfa expression decreased amount, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
ventral mandibular arch morphology, ameliorated
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
cranial motor neuron isl2a expression decreased amount, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|
myelinating Schwann cell myelination process quality, ameliorated
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
melanocyte dct expression decreased amount, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
perichondrium disorganized, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
head melanoblast mitfa expression decreased amount, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 4
from Asad et al., 2016
|
vagal neural crest crestin expression decreased amount, abnormal
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|
myelinating Schwann cell mbpa expression position, ameliorated
|
TU + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 6
from Asad et al., 2016
|
pharyngeal arch cartilage morphology, ameliorated
|
TU + MO4-sox10 + MO8-chd7
|
standard conditions
|
Fig. S7
from Asad et al., 2016
|
ventral mandibular arch morphology, ameliorated
|
TU + MO4-sox10 + MO8-chd7
|
standard conditions
|
Fig. S7
from Asad et al., 2016
|
myelinating Schwann cell mbpa expression position, ameliorated
|
TU + MO4-sox10 + MO8-chd7
|
standard conditions
|
Fig. S6
from Asad et al., 2016
|
Meckel's cartilage morphology, ameliorated
|
ba2Tg + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
olfactory receptor cell decreased amount, abnormal
|
ba2Tg + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|
ceratobranchial cartilage morphology, ameliorated
|
ba2Tg + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
ceratohyal cartilage morphology, ameliorated
|
ba2Tg + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. 7
from Asad et al., 2016
|
whole organism decreased pigmentation, abnormal
|
w47Tg + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. S4
from Asad et al., 2016
|
enteric neuron decreased amount, abnormal
|
zf148Tg + MO1-sox10 + MO8-chd7
|
standard conditions
|
Fig. S5
from Asad et al., 2016
|